Laevolac

Lactulose, the active ingredient in Laevolac, is an osmotic laxative presented as a liquid for oral use. It is employed to relieve constipation and to reduce blood ammonia levels in patients with hepatic encephalopathy, under the guidance of a qualified healthcare professional. It is available in a ready‑to‑drink formulation that can be measured and mixed according to prescriber instructions.

GNH USA supplies Laevolac as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent product availability, regulatory compliance and reliable logistics across EU and other markets.

Laevolac (lactulose) acts as an osmotic laxative and ammonia‑lowering agent in the gastrointestinal tract.

Constipation: softens stool and promotes bowel movements, helping relieve occasional or chronic constipation. Hepatic encephalopathy: lowers intestinal ammonia production, assisting in the management of hepatic encephalopathy in patients with liver disease.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Bloating: abdominal distension and discomfort. - Diarrhea: loose stools, especially with higher doses. - Nausea: mild queasiness. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Electrolyte imbalance: significant changes in potassium or sodium levels. - Severe abdominal pain: may indicate intestinal obstruction. - Allergic reaction: rash, itching, or swelling. - Dehydration: marked fluid loss leading to low blood pressure.

When using Laevolac, certain precautions should be observed to ensure safety and effectiveness.

- Dose adjustment: tailor the dose to individual response and clinical condition. - Fluid intake: maintain adequate hydration to reduce risk of dehydration. - Renal impairment: monitor kidney function and adjust dosing if necessary. - Diabetes: monitor blood glucose as lactulose may affect glucose metabolism. - Pediatric use: use under pediatric specialist guidance, dosing differs from adults. - Store at ambient temperature: keep below 25°C, retain in original container, protect from moisture.

Lactulose can interact with other medicines, affecting their absorption or therapeutic effect.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: may reduce lactulose efficacy by binding. - Oral antibiotics: broad‑spectrum agents can alter gut flora, diminishing lactulose metabolism.

Moderate Interactions (Monitor Closely): - Diuretics: increased risk of electrolyte disturbances when combined with lactulose‑induced diarrhea. - Insulin or oral hypoglycemics: monitor blood glucose as lactulose may affect glucose levels. - Proton pump inhibitors: may modify gastric pH and influence lactulose activity.